Página Nct de ensaios clínicos

Clinical Trial Results:
A Randomized, Open Label Multi-Center Study of XRP6258 At 25 mg/m2 in Combination With Prednisone Every 3 Weeks Compared To Mitoxantrone in Combination With Prednisone For The Treatment of Hormone Refractory Metastatic Prostate Cancer Previously Treated With A Taxotere®-Containing Regimen

Summary
EudraCT number
2006-003087-59
Trial protocol
CZ   DE   HU   BE   NL   SK   DK   SE   FI   IT   GB  
Global completion date
25 Sep 2009

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?
No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?
No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?
No

Results information
Results version number
v1(current)
This version publication date
12 May 2016
First version publication date
12 May 2016
Other versions
Summary report(s)
EFC6193
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.
3
Se inscrever